NCT06588686Phase 2Active not recruiting

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-05Estimated

Enrollment · participants378Actual

Source updated2026-08-17Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-05-01 · 2 fields changed

Participant count type changed

− Before

~~Estimated~~

+ After

Actual

Enrollment · participant count changed

− Before

~~360 participants (planned)~~

+ After

378 participants (actual)

Check registry source

Posted 2026-04-23 · 1 field changed

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source

Posted 2025-11-18 · 1 field changed

Primary completion date changed

− Before

~~Feb 2027~~

+ After

May 2027

Check registry source

Posted 2025-11-14 · 1 field changed

Planned enrollment increased by 90 participants

− Before

~~270 participants (planned)~~

+ After

360 participants (planned)

Check registry source